温阳类中药及复方抗肺癌作用机制研究进展OA
Anti-lung Cancer Mechanisms of Yang-warming Herbs and Formulas:A Review
肺癌尤其是非小细胞肺癌,是我国及全球范围内发病率、死亡率最高的恶性肿瘤,2022年全球死亡人数达180万,占癌症总死亡数18.7%,严重威胁人类健康和生命安全,防治形势严峻.尽管近年来肺癌治疗策略不断丰富,靶向及免疫治疗取得进展,但由于原发性或获得性耐药、免疫低应答及化疗毒性等问题,患者长期生存获益仍受限,亟须探索安全有效的辅助治疗策略.中医药凭借整体调节与个体化辨证优势,在肿瘤综合治疗中地位日益突出.中医认为"阳虚致积"是肿瘤关键病机,基于"阳化气,阴成形"理论,阳气亏虚致温煦失职,阴寒内聚,与现代医学中免疫微环境失调、"冷肿瘤"特征及神经内分泌系统功能紊乱密切相关,故"温阳扶正抗癌"策略日益受到重视.近年来,附子、干姜、肉桂、淫羊藿、补骨脂等常用温阳中药及其活性成分通过调控多条信号通路,诱导凋亡、抑制转移、逆转耐药等抗肺癌研究取得显著进展;此外,四逆汤、阳和汤等温阳复方在减轻骨髓抑制、改善癌因性疲乏、恶性胸腔积液及癌性疼痛方面亦展现良好前景,具有减毒增效作用,显著提升患者生活质量及生存获益.为系统梳理温阳类中药及复方在肺癌中的作用与机制,该文首次对近年来相关研究进行深入总结,旨在为中医药防治肺癌的临床实践提供思路.
Lung cancer,particularly non-small cell lung cancer(NSCLC),is the malignant tumor with the highest incidence and mortality in China and worldwide.In 2022,the global number of deaths reached 1.8 million,accounting for 18.7%of all cancer-related deaths,seriously threatening human health and life,and posing a severe challenge for prevention and treatment.Although treatment strategies for lung cancer have been continuously enriched in recent years,and progress has been made in targeted therapy and immunotherapy,long-term survival benefits remain limited due to primary or acquired drug resistance,low immune responsiveness,and chemotherapy-related toxicities.Therefore,there is an urgent need to explore safe and effective adjunctive therapeutic strategies.Traditional Chinese medicine(TCM),with its advantages of holistic regulation and individualized syndrome differentiation,has played an increasingly prominent role in comprehensive cancer treatment.TCM holds that"Yang deficiency leads to accumulation"is a key pathogenesis of tumors.Based on the theory that"Yang transforms Qi,while Yin forms substance",deficiency of Yang Qi results in impaired warming and transformation functions,leading to internal accumulation of Yin-cold.This is closely related to dysregulation of the immune microenvironment,"cold tumor"characteristics,and dysfunction of the neuroendocrine system in modern medicine.Accordingly,the therapeutic strategy of"warming Yang,supporting healthy Qi,and combating cancer"has gained increasing attention.In recent years,commonly used Yang-warming Chinese herbs,including Aconiti Lateralis Radix Praeparata,Zingiberis Rhizoma,Cinnamomi Cortex,Epimedii Folium,and Psoraleae Fructus,as well as their active constituents,have achieved notable progress in anti-lung cancer research by regulating multiple signaling pathways,inducing apoptosis,inhibiting metastasis,and reversing drug resistance.In addition,Yang-warming formulae such as Sini Tang and Yanghe Tang have shown promising effects in alleviating myelosuppression,improving cancer-related fatigue,managing malignant pleural effusion,and relieving cancer pain.These therapies exhibit toxicity-reducing and efficacy-enhancing effects,significantly improving patients' quality of life and survival benefits.To systematically summarize the roles and mechanisms of Yang-warming Chinese herbal medicines and compound formulae in lung cancer,this paper provides a comprehensive review of recent advances,aiming to offer insights for the clinical practice of TCM in the prevention and treatment of lung cancer.
徐波;余贻汉;齐淯;张继先;胡林凌;江波;邹义龙;范存愈;范艺龄;苗青
中国中医科学院西苑医院,北京 100091||中国中医科学院博士后流动站,北京 100700湖北省中西医结合医院,武汉 430015湖北中医药大学,武汉 430065||湖北时珍实验室,武汉 430065湖北省中西医结合医院,武汉 430015湖北中医药大学,武汉 430065||湖北省中西医结合医院,武汉 430015湖北省中西医结合医院,武汉 430015湖北省中西医结合医院,武汉 430015湖北省中西医结合医院,武汉 430015中国中医科学院西苑医院,北京 100091中国中医科学院西苑医院,北京 100091
医药卫生
肺癌温阳类中药活性成分温阳类复方抗肿瘤作用机制
lung cancerYang-warming herbal medicinesactive ingredientsYang-warming compound formulaeanti-tumor effectsmechanism of action
《中国实验方剂学杂志》 2026 (10)
70-79,10
湖北省中医药管理局重点项目(ZY2023Z003)国家优势专科建设项目(fm20242503)国家自然科学基金项目(82305228)
评论